Nicole Schlautmann is a new HR officer at MSD Österreich | Merck Sharp & Dohme

Nicole Schlautmann, the Geschäftsführung of MSD Österreich, passed away on October 1, 2024. With a number of studies in the pharmaceutical industry, Ina Herzer’s job is to move to Customer Experience Enablement Lead International in the coming years. Schlautmann is the strategic enterprise of the Unternehmens in Österreich, and the central Wachstumsinitiativen in the Bereichen Onkologie, Impfstoffe as well as Hospital and Specialty vorantreiben.

Focus on strategic planning and improved product development

In its new position with Nicole Schlautmann, the Leitung der Österreichische Niederlassung is responsible for the strategic Ausrichtung and Wachstum of MSD in Österreich. Because it is true that the Onkology department, as well as hospital and specialty care, pays special attention to the improvement of product innovation. This would play a role in the Sterreichische Landraad of the three Sterreichische positions and the development of the terreichensstrategy and initiatives going further.

Erfahrene Führungskraft with international expertise

Nicole Schlautmann came from Pfizer and became General Manager of Österreich during the war. If you have found a new way of working in the pharmaceutical industry, your positions at Pfizer and ORPHAN EUROPE SARL in Germany, France and the US have changed. You have a degree in Biology from the Westfälische Wilhelms-Universität Münster and an MBA from Purdue University in the US. „After spending more years with Pfizer if I now have a new Herausforderungen and Darauuf, my team with a strong team becomes a ​meiner Seite for a healthy Zukunft in Österreich in the Arbeiten. I am in my own right, that we are in a constructive environment with the benefits of the eastern health systems that can provide positive benefits for people and animals.”, said the new Geschäftsführerin.

Uber MSD

MSD is a global biopharmaceutical company with three locations and 950 Mitarbeiter:innen in Österreich. Since 130 years has passed since our mission, our life has been alive, our life has been transformed and we have lived our lives. Our first impression is that the illness of impediment or frühzeitig zu recognize and will be a fault of the healing of the damage or the quality of life of those affected. If an experienced business and fortification partner receives the best care at MSD, they can make a positive contribution to people’s lives and the region in Austria, so that they can also care for future generations. MSD Österreich is working on an intensive and innovative approach, a complex health problem is being solved. Our goal is to promote oncological, bacterial and viral infectious diseases, immunological and cardiovascular diseases, germs and the infection of inflammatory substances. We will make every effort for our life!

MSD is the Kurzform of Merck Sharp & Dohme Ges.mbH, the Austrian Tochtergesellschaft of Merck & Co., Inc., with Hauptsitz in Rahway, New Jersey, USA and good for 70,000 Mitarbeitern.

AT-NOT-02592 | September 2024